Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway

Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells

(2013) Ling Yang et al.   CANCER LETTERS

Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer

(2013) Perri Rozenberg et al.   INTERNATIONAL JOURNAL OF CANCER

Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin

(2011) Hui Yang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Mortalin–p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy

(2011) W-J Lu et al.   CELL DEATH AND DIFFERENTIATION

Crosstalk between Raf/MEK/ERK and PI3K/AKT in Suppression of Bax Conformational Change by Grp75 under Glucose Deprivation Conditions

(2011) Ling Yang et al.   JOURNAL OF MOLECULAR BIOLOGY

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Microenvironment and Pathogenesis of Epithelial Ovarian Cancer

(2010) Antonio F. Saad et al.   Hormones & Cancer

Ovarian Cancer Pathogenesis: A Model in Evolution

(2009) Alison M. Karst et al.   Journal of Oncology

Ovarian Cancer

(2008) Kathleen R. Cho et al.   Annual Review of Pathology-Mechanisms of Disease

Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer

(2008) Ajay P Singh et al.   LANCET ONCOLOGY

Ras oncogenes: split personalities

(2008) Antoine E. Karnoub et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY